ViralHep_GR_Perelman_www2012_v2.jpg 
Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.

Perelman School of Medicine Small JPEG                                                          VE logo 300px
Marion G. Peters MD
Kenneth E. Sherman MD PhD
Original Webcast:  Wednesday November 28th, 2012 12:00 PM EDT
Topic:  Treatment of HCV / HIV Co-infection
HIV / HEV Co-infection

This program was re-broadcast over the web for HIV Grand Rounds on 11/29/2012

Be sure to read through the program overview prior to registering and attending this program.

The registration window for this program is at the bottom of the page.

Series Overview:

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity HIV Grand Rounds that, in partnership with the Perelman School of Medicine at the University of Pennsylvania, has successfully run for over 2 years. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is delivered live via the Internet every fourth Wednesday of each month at 12:00 pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.

Target Audience:

The program has been designed for physicians, fellows, residents, medical students, nurses, nurse practitioners, physician assistants and allied health professionals in the medical specialties of Hepatology, Internal Medicine, Family Practice, Gastroenterology, as well as HIV/AIDS practitioners dealing with co-infection, other Infectious Disease specialists, Public Health professionals and other clinicians interested and involved in the care of patients with Hepatitis.

Commercial Support Acknowledgement:

These activities are supported by educational grants from Gilead Sciences Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc.

Learning Objectives for the Series:

Upon completion of the program, participants should be able to:

  • Improve knowledge and ability to use epidemiology and risk factors for increased detection of viral hepatitis.
  • Increase the rate of testing of viruses associated with hepatitis.
  • Improve knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral hepatitis.
  • Improve the treatment of viral hepatitis in patients co-infected with HIV or other viral infections.

Course Directors:

K. Rajender Reddy MD K. Rajender Reddy, MD

Professor of Medicine
Professor of Medicine in Surgery
Director, Viral Hepaitits Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Mark Sulkowski MD

Mark Sulkowski, MD

Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty:

  Marion G. Peters MD

Marion G. Peters, MD

John V. Carbone MD Endowed Chair
Professor of Medicine
Chief of Hepatology Research
University of California
San Francisco, California

  Kenneth E. Sherman MD PhD

Kenneth E. Sherman, MD PhD

Gould Professor of Medicine
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures:

It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Michael Schoen, PhD and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Brian Boyle MD, Richard Gordon and Oliver Fultz), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Kenneth E. Sherman MD PhD

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

Presenters Name

Commercial Supporter

Relationship

Planning Committee Members:

K. Rajender Reddy, MD

BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion

Contracted Research

  Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex

Consulting Fees

Mark Sulkowski, MD

Abbott; BIPI; BMS; Gilead; Janssen; Merck; Roche; Vertex

Contracted Research

 

Abbott; BIPI; BMS; Gilead; Janssen; Novartis; Pfizer; Roche; Vertex

Consulting Fees

Faculty:

Marian G. Peters MD

Biotron; Clinical Care Options; Internatinal Antiviral Society (IAS-USA);Theravance 2012

Advisory Board Member

 

International Antiviral Society (IAS-USA); Roche

Speaker/honorarium

 

Spouse is an employeeGenentech Research and Development (Subsidiary of Roche)

Spouse is an employee

Discussion of Investigational and/or Off-label Use of commercial products and devices:

The Perelman School of Medicine at the University of Pennsylvania Requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

register:

Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania: Wednesday November 28th, 2012 Week 3
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *

**To receive CME credit, click here.

§ Using this button will send you directly to the on-demand program without the opportunity to receive CME credit.

* Required

**Clicking the "I would like to receive CME credit" button will bring you to the Perelman School of Medicine at the University of Pennsylvania Office of CME website program information page. After registering or logging in please follow the instructions on this page.

§ Choosing "Please send me directly to the program" will bring you directly to the webcast to view this program which will start automatically. By accessing the program this way you will NOT be eligible to receive CME credit.